Issue 2 (2023)

Summary

Articles

The Psychosocial Impact of Congenital Cytomegalovirus on Caregivers and Families: Lived Experiences and Review of the Literature
Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
Implementation of Newborn Hearing Screening in Albania
Information and Parental Consent for French Neonatal Screening: A Qualitative Study on Parental Opinion
Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand
Foetal Haemoglobin as a Marker of Bone Marrow Suppression Secondary to Anti-Kell Alloimmunisation
Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
Genomic-Based Newborn Screening for Inborn Errors of Immunity: Practical and Ethical Considerations
Newborn Screening in a Pandemic—Lessons Learned
Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018
Newborn Screening Knowledge, Attitudes and Practices among Obstetrics-Gynecology Residents, Pediatric Residents, and Newborn Screening Nurses in a Tertiary Government Hospital in the Philippines during the COVID-19 Pandemic
Newborn Screening Long-Term Follow-Up Clinics (Continuity Clinics) in the Philippines during the COVID-19 Pandemic: Continuing Quality Patient Care
A Retrospective Evaluation of the Predictive Value of Newborn Screening for Vitamin B12 Deficiency in Symptomatic Infants Below 1 Year of Age
Congenital Cytomegalovirus Screening in Massachusetts Birth Hospitals: A Statewide Survey
Technical Study of Automated High-Throughput High-Sensitive Ceruloplasmin Assay on Dried Blood Spots—Reinstate the Potential Use for Newborn Screening of Wilson Disease
Assessing the Content Quality of Online Parental Resources about Newborn Metabolic Disease Screening: A Content Analysis
Liquid Chromatography–Tandem Mass Spectrometry in Newborn Screening Laboratories
A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease
Inconsistent Provider Testing Practices for Congenital Cytomegalovirus: Missed Diagnoses and Missed Opportunities
Parental Depression and Anxiety Associated with Newborn Bloodspot Screening for Rare and Variable-Onset Disorders
Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors
Multiple 17-OHP Cutoff Co-Variates Fail to Improve 21-Hydroxylase Deficiency Screening Accuracy
Evaluation of a New Laboratory Protocol for Newborn Screening for Congenital Adrenal Hyperplasia in New Zealand
Parental Preferences about Policy Options Regarding Disclosure of Incidental Genetic Findings in Newborn Screening: Using Videos and the Internet to Educate and Obtain Input
Psychosocial Issues Related to Newborn Screening: A Systematic Review and Synthesis
Changes in the Incidence of Infantile Spinal Muscular Atrophy in Shikoku, Japan between 2011 and 2020
Newborn Screening Is on a Collision Course with Public Health Ethics
Newborn Screening for Duchenne Muscular Dystrophy: First Year Results of a Population-Based Pilot
Developing an Online Dashboard to Visualize Performance Data—Tennessee Newborn Screening Experience
Family Perspectives on Newborn Screening for X-Linked Adrenoleukodystrophy in California
A Novel System for Spinal Muscular Atrophy Screening in Newborns: Japanese Pilot Study
Next Generation Sequencing in Newborn Screening in the United Kingdom National Health Service
Development of a Multiplex Real-Time PCR Assay for the Newborn Screening of SCID, SMA, and XLA
Incidence of Glucose-6-Phosphate Dehydrogenase Deficiency among Swedish Newborn Infants
Newborn Screening: Current Status in Alberta, Canada
Editorial for Special Issue “Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies”
Factors Influencing Parental Awareness about Newborn Screening
Development of National Newborn Screening Quality Indicators in the United States
Wisconsin’s Screening Algorithm for the Identification of Newborns with Congenital Adrenal Hyperplasia
Initial Evaluation of Prospective and Parallel Assessments of Cystic Fibrosis Newborn Screening Protocols in Eastern Andalusia: IRT/IRT versus IRT/PAP/IRT
The Reliable, Automatic Classification of Neonates in First-Tier MALDI-MS Screening for Sickle Cell Disease
Newborn Sickle Cell and Thalassaemia Screening Programme: Automating and Enhancing the System to Evaluate the Screening Programme